在腹和便秘中血清素水平 - 主要是刺激性肠综合征
Elif Tugba Tuncel1, Seda Sabah Ozcan2, Mehmet Korkmaz2
1Faculty of Medicine Department of Gastroenterology, Celal Bayar University, Manisa, Turkey.
PeerJ
|February 3, 2025
概括
在腹占主导地位的刺激性肠综合征 (IBS) 患者中,素水平显著降低. 这一发现表明素可能有助于诊断和预测IBS,这是一种与肠道炎症相关的疾病.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 炎症和免疫力是功能性肠道疾病的关键因素.
- 沙因其易于收集和可靠性而成为新兴的生物标志物.
- 以前的研究将沙素与炎症过程和氧化损伤联系起来.
研究的目的:
- 为了研究血清素水平在刺激性肠病 (IBD) 的诊断和预测价值.
- 分析盐素水平和IBS亚型之间的关系.
主要方法:
- 与酶相关的免疫吸收试验 (ELISA) 用于测量血清素水平.
- 研究包括28名便秘占主导地位的IBS,29名腹占主导地位的IBS (D-IBS) 和28名对照参与者.
- 参与者的人口统计:50名女性 (58.8%) 和35名男性 (41.2%).
主要成果:
- 与对照组相比,D-IBS组的血清素α水平大幅降低.
- 在便秘占主导地位的IBS和D-IBS组之间没有观察到盐素水平的显著差异.
- 在素水平和D-IBS亚组之间发现了显著的预后关系.
结论:
- 降低素水平与D-IBS有关.
- 沙素显示出作为诊断,预测和可能治疗IBS的生物标志物的潜力.
- 需要进一步的研究来探索沙素与胃肠道疾病 (如IBS) 之间的联系,这种疾病与低度的肠道炎症有关.
相关概念视频
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
118
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
118
Drugs for Treatment of Diarrhea-Predominant IBS
142
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
142
Irritable Bowel Syndrome I: Introduction
234
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
234
Drugs for Treatment of Constipation-Predominant IBS
130
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
130
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
306
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
306
Chronic Bowel Disorders: Introduction
385
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
385


